Aura Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	59.52	31.69	41.06	121.58	149.06
Short-Term Investments	84.73	119.4	185.09	67.23	-
Cash & Short-Term Investments	144.24	151.09	226.15	188.81	149.06
Cash Growth	-4.54%	-33.19%	19.78%	26.66%	757.03%
Other Current Assets	5.5	9.53	5.64	7.89	4.64
Total Current Assets	149.74	160.62	231.79	196.7	153.7
Net Property, Plant & Equipment	18.45	20.59	22	26.04	6.2
Other Long-Term Assets	1.24	1.29	1.28	1.19	0.13
Total Assets	169.43	182.5	255.08	223.94	160.03
Accounts Payable	1.55	2.3	1.79	2.92	2.4
Accrued Expenses	13.59	9.46	7.88	4.57	4.34
Current Portion of Leases	3.24	3.15	2.69	2.96	0.62
Total Current Liabilities	18.38	14.91	12.36	10.46	7.36
Long-Term Leases	14.13	15.62	16.87	17.9	0.36
Total Long-Term Liabilities	14.13	15.62	16.87	17.9	0.36
Total Liabilities	32.52	30.53	29.23	28.35	7.72
Additional Paid-in Capital	617.43	525.93	512.62	406.56	304.45
Accumulated Other Comprehensive Income	-0.1	0.26	0.54	-0.07	-
Retained Earnings	-480.42	-374.23	-287.31	-210.9	-152.14
Total Common Shareholders' Equity	136.91	151.97	225.85	195.58	152.32
Shareholders' Equity	136.91	151.97	225.85	195.58	152.32
Total Liabilities & Equity	169.43	182.5	255.08	223.94	160.03
Total Debt	17.38	18.77	19.56	20.86	0.98
Net Cash (Debt)	126.86	132.33	206.59	167.95	148.09
Net Cash Growth	-4.13%	-35.95%	23.01%	13.41%	751.42%
Net Cash Per Share	2.10	2.67	5.21	5.61	28.70
Book Value	136.91	151.97	225.85	195.58	152.32
Book Value Per Share	2.27	3.06	5.70	6.53	29.52
Tangible Book Value	136.91	151.97	225.85	195.58	152.32
Tangible Book Value Per Share	2.27	3.06	5.70	6.53	29.52

Updated Mar 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q